OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 7
Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 7
Showing 7 citing articles:
A nitrosyl iron complex with 3.4-dichlorothiophenolyl ligands: synthesis, structures and its reactions with targets – carriers of nitrogen oxide (NO) in vivo
Оlesya V. Pokidova, Veronika O. Novikova, N. S. Emel’yanova, et al.
Dalton Transactions (2023) Vol. 52, Iss. 9, pp. 2641-2662
Closed Access | Times Cited: 14
Оlesya V. Pokidova, Veronika O. Novikova, N. S. Emel’yanova, et al.
Dalton Transactions (2023) Vol. 52, Iss. 9, pp. 2641-2662
Closed Access | Times Cited: 14
Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent
Guiming Hu, Yan Fang, Hai‐Wei Xu, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 11
Guiming Hu, Yan Fang, Hai‐Wei Xu, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 11
In silico evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in Pleurotus ostreatus extracts
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23744-23771
Open Access | Times Cited: 4
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23744-23771
Open Access | Times Cited: 4
Discovery of a CYP2E1 Inhibitor and Its Therapeutic Potential in Severe Acute Pancreatitis
Jinhuan Qiu, Jiakun Lu, Xiaodi Wang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117666-117666
Closed Access
Jinhuan Qiu, Jiakun Lu, Xiaodi Wang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117666-117666
Closed Access
Discovery of CYP2E1 as a novel target in rheumatoid arthritis and validation by a new specific CYP2E1 inhibitor
Zixinying Han, Chenxu Liu, Mingrui Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116501-116501
Closed Access | Times Cited: 2
Zixinying Han, Chenxu Liu, Mingrui Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116501-116501
Closed Access | Times Cited: 2
Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis
Yuhan Gu, Yan Fang, Yuanyuan Guo, et al.
International Journal of Biological Macromolecules (2024), pp. 139189-139189
Closed Access | Times Cited: 1
Yuhan Gu, Yan Fang, Yuanyuan Guo, et al.
International Journal of Biological Macromolecules (2024), pp. 139189-139189
Closed Access | Times Cited: 1
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization
Cunzhen Zhang, Yan Fang, Mengxue Guo, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Cunzhen Zhang, Yan Fang, Mengxue Guo, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
